Triple
T13318873
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Cortellis |
E317262
|
entity |
| Predicate | hasComponent |
P35
|
FINISHED |
| Object | Cortellis Drug Discovery Intelligence |
E317262
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Cortellis Drug Discovery Intelligence | Statement: [Cortellis, hasComponent, Cortellis Drug Discovery Intelligence]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Cortellis Drug Discovery Intelligence Context triple: [Cortellis, hasComponent, Cortellis Drug Discovery Intelligence]
-
A.
Cortellis
chosen
Cortellis is a life sciences intelligence and analytics platform that provides pharmaceutical and biotech companies with data and insights to support drug discovery, development, and commercialization decisions.
-
B.
Medidata Solutions
Medidata Solutions is a life sciences technology company best known for its cloud-based clinical trial and research platforms used by pharmaceutical, biotech, and medical device organizations.
-
C.
BIOVIA
BIOVIA is a Dassault Systèmes software brand focused on scientific informatics and molecular modeling solutions for life sciences, materials science, and chemistry.
-
D.
SciFinder-n
SciFinder-n is a comprehensive research discovery platform from Chemical Abstracts Service that enables scientists to search and analyze chemical substances, reactions, literature, and related scientific data.
-
E.
Inflectra
Inflectra is a biosimilar monoclonal antibody to infliximab used to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d806b4d62c81908d4ced1665414be5 |
completed | April 9, 2026, 8:06 p.m. |
| NER | Named-entity recognition | batch_69d990faa95481908a7fd297959c062e |
completed | April 11, 2026, 12:08 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69f716ee695c81909ffeeb0901ee66c1 |
completed | May 3, 2026, 9:35 a.m. |
Created at: April 9, 2026, 9:29 p.m.